Entries by nephstrom_admin

NEPHSTROM features on BBC News

The project received excellent coverage from the BBC on 20 October, focusing on the cell production taking place at NHSBT. The item (at http://www.bbc.com/news/health-34570550) gives a concise overview of the project, and quotes both coordinator Prof Tim O’Brien (NUIG) and the NHSBT’s Dr Eric Austen.

LMU Munich Press Release

LMUM distributed a press release about NEPHSTROM, aimed at the German-language press and public.   The full text was as follows: Neue Klinische Studie zur Stammzelltherapie bei diabetischer Nierenschädigung 24.06.2015 – Die Arbeitsgruppe um Prof. Hans-Joachim Anders am Nephrologischen Zentrum der Medizinischen Klinik und Poliklinik IV leitet ein Teilprojekt in dem EU-Projekt NEPHSTROM (Novel Stromal […]

Great further media coverage of NEPHSTROM

The launch of the NEPHSTROM project received further excellent coverage in the media, social media and EU vehicles. Coverage now includes all the following: RTÉ Radio 1 News (RTE is the Irish national broadcaster) 8 June, at 7am and 8am 9am (during Morning Ireland) clips are 1 minute 30 seconds long http://broadcast.kantarmedia.ie/proxy/MediaLibrary/MediaLibrary.mp3/?clipId=59736763 http://broadcast.kantarmedia.ie/proxy/MediaLibrary/MediaLibrary.mp3/?clipId=59737626 RTÉ One News, […]

EU MSC2 2015: Contributing to MSC Knowledge-Sharing, Research & Development

Our sister project REDDSTAR and Leiden University Medical Center are co-organizing EU MSC2 2015, a meeting in Leiden, NL on September 7th and 8th to bring together nine EU-funded, mesenchymal stromal cell-focussed consortia. Projects include: REDDSTAR, REACH, RETHRIM, Stellar, MERLIN, Nephstrom, SCIENCE, VISICORT and Adipoa-2. This two day, interactive meeting will be held at the […]

NEPHSTROM Kick-off Meeting a great success

The NEPHSTROM consortium met for its kick-off meeting in Dublin on 9 June. All partners were represented, with the meeting chaired by coordinator Tim O’Brien of NUI Galway. In-depth workshops were held on GMP production and technology, and on the details of the clinical trial, with excellent progress made on the integration of partner efforts […]